How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,691 results for

Gestational Diabetes Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

4801. Hypoglycemia: Physician and Patient Perspectives

Summary: The purpose of this study is to assess the burden of hypoglycemia and identify unmet need related to the management of hypoglycemia among Type 2Diabetes Mellitus (T2DM) patients on OADs and/or insulin. This is an observational study which will identify patients with T2DM in an administrative claims database and will link claims data with results of patient and physician surveys concerning hypoglycemia. Condition or disease Type 2 Diabetes Mellitus Hypoglycemia Study Design Go to Layout table (...) via mail into the survey portion of this study. Survey results will be linked to actual patient care using the claims records. Criteria Inclusion Criteria: T2DM claims diagnosis (algorithm-based) with at least 2 pharmacy claims for an antidiabetic drug at least 1 HbA1c test recorded during the identification period continuous enrollment in the health plan for at least 12 months prior to survey date Exclusion Criteria: Type 1 Diabetes Mellitus pregnancy or gestational diabetes Contacts

2010 Clinical Trials

4802. Folic Acid Dosage and Malformations Reduction

Folic Acid Dosage and Malformations Reduction Folic Acid Dosage and Malformations Reduction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Folic Acid Dosage and Malformations Reduction The safety (...) . Women who have a pregnancy diagnosis during the study period will be interviewed by telephone at the expected 16, 24 and 40 weeks of gestation to evaluate the pregnancy outcome. The health status of live births will be evaluated at the child's age of 1 month, 3 months and 1 year. The primary aim of this project is conducting a study to assess the effect of folic acid periconceptional supplementation of 4 mg/day compared to the 0.4 mg/day standard dose on reducing the occurrence of all congenital

2010 Clinical Trials

4803. Ephedrine vs Phenylephrine

Ephedrine vs Phenylephrine Ephedrine vs Phenylephrine - ECG Changes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Ephedrine vs Phenylephrine - ECG Changes The safety and scientific validity of this study (...) debated, and apart from a few case reports do not appear to be associated with poor heart muscle function or ischaemia (lack of oxygen supply). Management of the mother's blood pressure during caesarean section has changed greatly in recent years. Intermittent boluses of ephedrine, given when blood pressure is low, have been replaced with prevention of low blood pressure and phenylephrine has become the drug of choice. Ephedrine increases heart rate and contractility of the heart muscle and is likely

2010 Clinical Trials

4804. Subcuticular Suture Versus Staples for Closure of the Skin After Caesarean Section.

ordered more than 30 minutes before surgery is started. Woman who speak and understand Danish Woman who can give informed consent. Exclusion Criteria: Level I or II caesarean section (ordered less than 30 min. before surgery is started). Diabetics (this does not include gestational diabetes). Infection Regular treatment with immunosuppressives Alcohol or drug abuse Age under 18 Chronic pain disease eg fibromyalgia, rheumatoid arthritis BMI over 35 Previous abdominal surgery through lower transverse (...) Subcuticular Suture Versus Staples for Closure of the Skin After Caesarean Section. Subcuticular Suture Versus Staples for Closure of the Skin After Caesarean Section. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2010 Clinical Trials

4805. Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®

Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen® - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) appropriate for gestational age (AGA) and those born small for gestation age (SGA) after 4 weeks of Saizen therapy. Condition or disease Intervention/treatment Phase Dwarfism, Pituitary Drug: Recombinant human growth hormone (r-hGH) Phase 4 Detailed Description: The response to growth hormone (GH) treatment, short-term as well as long-term, displays considerable inter individual variability. This is particularly evident for the endpoint of paediatric GH administration, that is (i.e.) the growth response

2010 Clinical Trials

4806. Study Comparing Two Isoforms of Vitamin D Supplements for Infants

of gestational diabetes or hypertension in pregnancy; chronic alcohol use; malabsorption syndromes (Celiac disease, Crohn's, etc.), due to malabsorption of fat soluble vitamins Mothers taking any medications that can affect vitamin D metabolism (anticonvulsants and corticosteroids) Mothers taking ≥ 2,000 IU/d of vitamin D from supplementation Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff (...) Study Comparing Two Isoforms of Vitamin D Supplements for Infants Study Comparing Two Isoforms of Vitamin D Supplements for Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study Comparing Two

2010 Clinical Trials

4807. National Pregnancy Registry for Atypical Antipsychotics

to atypical antipsychotics during the first trimester of pregnancy. This data is collected through pediatric medical record review through the first six months of infants' lives. Secondary Outcome Measures : Maternal health outcomes [ Time Frame: During pregnancy ] Maternal health outcomes during pregnancy will also be assessed in women taking atypical antipsychotics during pregnancy (for example: weight gain, gestational hypertension, gestational diabetes, preeclampsia) Neonatal health outcomes [ Time (...) National Pregnancy Registry for Atypical Antipsychotics National Pregnancy Registry for Atypical Antipsychotics - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. National Pregnancy Registry for Atypical

2010 Clinical Trials

4808. A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene

to starting study drug and Acute Myocardial Infarction (AMI) ≤ 3 months prior to starting study drug. Patients with clinically manifest diabetes mellitus, history of gestational diabetes mellitus or documented steroid-induced diabetes mellitus Women who are pregnant or breast feeding or adults of reproductive potential not employing an effective method of birth control Other protocol-defined inclusion/exclusion criteria may apply Contacts and Locations Go to Information from the National Library (...) A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum

2010 Clinical Trials

4809. Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)

Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached (...) characterized by a wide spectrum of clinical manifestations such as obesity, hirsutism, insulin resistance, diabetes and presence of specific ultrasonic features. Cetrotide®, cetrorelix acetate, is an antagonist of luteinizing-hormone-releasing hormone (LHRH). Cetrotide® is registered in 70 countries (including France) for the prevention of premature ovulation in subjects undergoing a controlled ovarian stimulation, followed by oocyte pick-up and ARTs. Ovitrelle®, active ingredient human chorionic

2010 Clinical Trials

4810. Intrapartum Hydration

table for eligibility information Ages Eligible for Study: 18 Years to 50 Years (Adult) Sexes Eligible for Study: Female Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Nulliparous women Gestational age 37-41 weeks Cervical dilatation 1-3 cm Vertex presentation Singleton Exclusion Criteria: Diabetes Preeclampsia Intra uterine fetal growth restriction Duration of labor less than an hour Maternal chronic disease Maternal fever upon admission. Contacts and Locations Go to Information from (...) Intrapartum Hydration Intrapartum Hydration - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Intrapartum Hydration The safety and scientific validity of this study is the responsibility of the study sponsor

2010 Clinical Trials

4811. Prevention of Intraoperative Nausea and Vomiting During Cesarean Section

Prevention of Intraoperative Nausea and Vomiting During Cesarean Section Prevention of Intraoperative Nausea and Vomiting During Cesarean Section - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Prevention (...) : Interventional (Clinical Trial) Actual Enrollment : 306 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) Primary Purpose: Prevention Official Title: The Effect of Adding Metoclopramide and Ondansetron to a Prophylactic Phenylephrine Infusion for the Management of Nausea and Vomiting Associated With Spinal Anesthesia for Cesarean Section Study Start Date : December 2008 Actual Primary Completion Date

2010 Clinical Trials

4812. Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants

for eligibility information Ages Eligible for Study: 37 Weeks to 42 Weeks (Child) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: non-smoking mother healthy mother (no hemolytic disease, no treatment with any of the following drugs: anticonvulsants, antidepressants, thyroid hormone, insulin, chemotherapy or cortisone), normal pregnancy (no preeclampsia, no diabetes, no prolonged rupture of membranes or signs of infection) single birth, term pregnancy (gestational age (...) Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants Early Versus Delayed Cord Clamping at Term: Outcomes in Swedish Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Early Versus

2010 Clinical Trials

4813. Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana

) Haemoglobin ≥ 7g/dl. Exclusion Criteria: i) Confirmed multiple gestation. ii) Severe malaria or disease likely to influence pregnancy outcome eg renal/ cardiac disease, diabetes mellitus, known pregnancy induced hypertension, known human immunodeficiency virus infection. iii) Known allergies to study medication. iv) Antimalarial treatment administered by a third party during the follow-up. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you (...) Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in Ghana - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2010 Clinical Trials

4814. Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour

or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 14 Years to 40 Years (Child, Adult) Sexes Eligible for Study: Female Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Indication of early elective delivery by induction of labor (pre-eclampsia, HELLP syndrome, chronic hypertension, prolonged gestation, diabetes mellitus, gestational diabetes, heart disease, thyroid (...) Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour Evaluation the Blood Loss in Pregnancies With Misoprostol-induced Labour - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Evaluation

2010 Clinical Trials

4815. Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques

gestational diabetes. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01230632 Locations Layout table for location information Australia, South Australia Leonie Heilbronn Adelaide, South Australia, Australia, 5000 Sponsors and Collaborators University (...) Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2010 Clinical Trials

4816. Depot Contraception With and Without Lopinavir/Ritonavir

risk factors for arterial cardiovascular disease Vascular disease Previous or current venous thromboembolism (VTE) or pulmonary embolism (PE) Ischaemic heart disease Stroke (history of cerebrovascular accident) Headaches migraine with aura, at any age Unexplained vaginal bleeding Gestational trophoblastic neoplasia (GTN) (includes hydatidiform mole, invasive mole, placental site trophoblastic tumour) hCG abnormal Breast cancer (past or current) or strong family history Diabetes nephropathy (...) Depot Contraception With and Without Lopinavir/Ritonavir Depot Contraception With and Without Lopinavir/Ritonavir - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Depot Contraception With and Without

2010 Clinical Trials

4817. Grain Exercise Trial

, Layout table for eligibility information Ages Eligible for Study: 20 Years to 90 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: increased waist circumference (≥84 cm in women and ≥98 cm in men) AND at least one additional cardiovascular risk factor: hypertension, diabetes type 2, prior coronary heart disease, prior stroke/TIA, peripheral arterial disease, impaired glucose tolerance, prior gestational diabetes, heredity or smoking (...) Grain Exercise Trial Grain Exercise Trial - Whole Grain Versus no Grain With or Without Physiotherapy-promoted Exercise for Waist Loss - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Grain Exercise Trial

2010 Clinical Trials

4818. Vaginal Progesterone as a Treatment for Women Active Preterm Labor

Eligible for Study: Female Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Age 18 or older Singleton gestation Gestational age between 24 0/7 and 33 6/7 weeks of pregnancy by best obstetric estimate Preterm labor, defined as more than 6 uterine contractions in 30 minutes associated with cervical change, either shortening and/or dilation by manual exam. Management with standard of care tocolytic therapy (nifedipine) Planned delivery at Strong Memorial Hospital or Highland Hospital Exclusion (...) Vaginal Progesterone as a Treatment for Women Active Preterm Labor Vaginal Progesterone as a Treatment for Women Active Preterm Labor - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Vaginal Progesterone

2010 Clinical Trials

4819. Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants

Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) was: Recruiting First Posted : September 22, 2010 Last Update Posted : June 23, 2011 Sponsor: American University of Beirut Medical Center Information provided by: American University of Beirut Medical Center Study Details Study Description Go to Brief Summary: The hypothesis of the study is that administration of antenatal steroid to women at high risk of preterm birth after 34 weeks of gestation would reduce the risk of respiratory complications, specifically Respiratory Distress Syndrome (RDS) or Transient

2010 Clinical Trials

4820. Impact of Pelvic Floor Musculature on Peripartum Outcomes

Impact of Pelvic Floor Musculature on Peripartum Outcomes Impact of Pelvic Floor Musculature on Peripartum Outcomes - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Impact of Pelvic Floor Musculature (...) Musculature on Peripartum Outcomes: A Prospective Study Study Start Date : April 2010 Actual Primary Completion Date : January 2014 Actual Study Completion Date : January 2014 Groups and Cohorts Go to Outcome Measures Go to Primary Outcome Measures : Serial changes in pelvic floor anatomy and function [ Time Frame: 12-24 weeks, 34-39 weeks gestation, and 4-6 weeks postpartum ] To evaluate the serial changes in pelvic floor anatomy and function during the second, third trimester of pregnancy

2010 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>